nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—Malabsorption—Octreotide—thymus cancer	0.0967	0.105	CcSEcCtD
Risedronate—Hernia—Octreotide—thymus cancer	0.0299	0.0324	CcSEcCtD
Risedronate—Abdominal bloating—Octreotide—thymus cancer	0.0295	0.0319	CcSEcCtD
Risedronate—Rectal disorder—Octreotide—thymus cancer	0.0286	0.031	CcSEcCtD
Risedronate—Anorectal disorder—Octreotide—thymus cancer	0.0267	0.0289	CcSEcCtD
Risedronate—Multiple fractures—Octreotide—thymus cancer	0.0242	0.0262	CcSEcCtD
Risedronate—Fracture—Octreotide—thymus cancer	0.0242	0.0262	CcSEcCtD
Risedronate—Haemorrhoids—Octreotide—thymus cancer	0.0239	0.0259	CcSEcCtD
Risedronate—Neuralgia—Octreotide—thymus cancer	0.0202	0.0219	CcSEcCtD
Risedronate—Herpes zoster—Octreotide—thymus cancer	0.0186	0.0202	CcSEcCtD
Risedronate—Otitis media—Octreotide—thymus cancer	0.018	0.0195	CcSEcCtD
Risedronate—Nephrolithiasis—Octreotide—thymus cancer	0.0175	0.0189	CcSEcCtD
Risedronate—Endocrine disorder—Octreotide—thymus cancer	0.0169	0.0183	CcSEcCtD
Risedronate—Contusion—Octreotide—thymus cancer	0.0161	0.0174	CcSEcCtD
Risedronate—Arthropathy—Octreotide—thymus cancer	0.0154	0.0167	CcSEcCtD
Risedronate—Eructation—Octreotide—thymus cancer	0.0138	0.0149	CcSEcCtD
Risedronate—Cystitis noninfective—Octreotide—thymus cancer	0.0137	0.0149	CcSEcCtD
Risedronate—Influenza like illness—Octreotide—thymus cancer	0.0136	0.0148	CcSEcCtD
Risedronate—Cystitis—Octreotide—thymus cancer	0.0136	0.0147	CcSEcCtD
Risedronate—Cramps of lower extremities—Octreotide—thymus cancer	0.0129	0.014	CcSEcCtD
Risedronate—Bladder pain—Octreotide—thymus cancer	0.0127	0.0137	CcSEcCtD
Risedronate—Gastroenteritis—Octreotide—thymus cancer	0.0115	0.0125	CcSEcCtD
Risedronate—Injury—Octreotide—thymus cancer	0.0111	0.012	CcSEcCtD
Risedronate—Arthritis—Octreotide—thymus cancer	0.0105	0.0114	CcSEcCtD
Risedronate—FDPS—hematopoietic system—thymus cancer	0.0104	0.136	CbGeAlD
Risedronate—Pain in extremity—Octreotide—thymus cancer	0.0102	0.011	CcSEcCtD
Risedronate—Osteoarthritis—Octreotide—thymus cancer	0.0102	0.011	CcSEcCtD
Risedronate—Abdominal pain upper—Octreotide—thymus cancer	0.00931	0.0101	CcSEcCtD
Risedronate—Nasopharyngitis—Octreotide—thymus cancer	0.00911	0.00987	CcSEcCtD
Risedronate—Gastritis—Octreotide—thymus cancer	0.00902	0.00977	CcSEcCtD
Risedronate—Muscular weakness—Octreotide—thymus cancer	0.00899	0.00973	CcSEcCtD
Risedronate—Abdominal distension—Octreotide—thymus cancer	0.00886	0.0096	CcSEcCtD
Risedronate—Influenza—Octreotide—thymus cancer	0.00881	0.00954	CcSEcCtD
Risedronate—Asthma—Octreotide—thymus cancer	0.00881	0.00954	CcSEcCtD
Risedronate—Bronchitis—Octreotide—thymus cancer	0.00847	0.00917	CcSEcCtD
Risedronate—Abdominal discomfort—Octreotide—thymus cancer	0.00844	0.00914	CcSEcCtD
Risedronate—Upper respiratory tract infection—Octreotide—thymus cancer	0.00818	0.00887	CcSEcCtD
Risedronate—FDPS—cardiac atrium—thymus cancer	0.00792	0.103	CbGeAlD
Risedronate—Pneumonia—Octreotide—thymus cancer	0.0079	0.00855	CcSEcCtD
Risedronate—Depression—Octreotide—thymus cancer	0.00783	0.00848	CcSEcCtD
Risedronate—FDPS—pituitary gland—thymus cancer	0.00773	0.101	CbGeAlD
Risedronate—Urinary tract infection—Octreotide—thymus cancer	0.00763	0.00827	CcSEcCtD
Risedronate—Conjunctivitis—Octreotide—thymus cancer	0.00763	0.00827	CcSEcCtD
Risedronate—Hepatobiliary disease—Octreotide—thymus cancer	0.00743	0.00804	CcSEcCtD
Risedronate—Sinusitis—Octreotide—thymus cancer	0.00737	0.00798	CcSEcCtD
Risedronate—FDPS—lymphoid tissue—thymus cancer	0.00734	0.0955	CbGeAlD
Risedronate—Rhinitis—Octreotide—thymus cancer	0.00707	0.00765	CcSEcCtD
Risedronate—Pharyngitis—Octreotide—thymus cancer	0.007	0.00758	CcSEcCtD
Risedronate—Oedema peripheral—Octreotide—thymus cancer	0.00694	0.00752	CcSEcCtD
Risedronate—FDPS—bone marrow—thymus cancer	0.00668	0.087	CbGeAlD
Risedronate—FDPS—thyroid gland—thymus cancer	0.00667	0.0867	CbGeAlD
Risedronate—Tinnitus—Octreotide—thymus cancer	0.00657	0.00712	CcSEcCtD
Risedronate—Cardiac disorder—Octreotide—thymus cancer	0.00654	0.00709	CcSEcCtD
Risedronate—Immune system disorder—Octreotide—thymus cancer	0.00637	0.0069	CcSEcCtD
Risedronate—Arrhythmia—Octreotide—thymus cancer	0.0063	0.00682	CcSEcCtD
Risedronate—Mental disorder—Octreotide—thymus cancer	0.00618	0.00669	CcSEcCtD
Risedronate—Malnutrition—Octreotide—thymus cancer	0.00614	0.00665	CcSEcCtD
Risedronate—FDPS—lung—thymus cancer	0.00605	0.0788	CbGeAlD
Risedronate—Flatulence—Octreotide—thymus cancer	0.00605	0.00655	CcSEcCtD
Risedronate—Back pain—Octreotide—thymus cancer	0.00594	0.00643	CcSEcCtD
Risedronate—Muscle spasms—Octreotide—thymus cancer	0.0059	0.00639	CcSEcCtD
Risedronate—Anaemia—Octreotide—thymus cancer	0.00567	0.00614	CcSEcCtD
Risedronate—Vertigo—Octreotide—thymus cancer	0.00551	0.00597	CcSEcCtD
Risedronate—Syncope—Octreotide—thymus cancer	0.0055	0.00596	CcSEcCtD
Risedronate—Loss of consciousness—Octreotide—thymus cancer	0.00539	0.00584	CcSEcCtD
Risedronate—Cough—Octreotide—thymus cancer	0.00535	0.0058	CcSEcCtD
Risedronate—Hypertension—Octreotide—thymus cancer	0.0053	0.00574	CcSEcCtD
Risedronate—Arthralgia—Octreotide—thymus cancer	0.00522	0.00566	CcSEcCtD
Risedronate—Chest pain—Octreotide—thymus cancer	0.00522	0.00566	CcSEcCtD
Risedronate—Myalgia—Octreotide—thymus cancer	0.00522	0.00566	CcSEcCtD
Risedronate—Anxiety—Octreotide—thymus cancer	0.00521	0.00564	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00519	0.00562	CcSEcCtD
Risedronate—Dry mouth—Octreotide—thymus cancer	0.00511	0.00553	CcSEcCtD
Risedronate—Infection—Octreotide—thymus cancer	0.00497	0.00539	CcSEcCtD
Risedronate—Shock—Octreotide—thymus cancer	0.00493	0.00534	CcSEcCtD
Risedronate—Nervous system disorder—Octreotide—thymus cancer	0.00491	0.00532	CcSEcCtD
Risedronate—Skin disorder—Octreotide—thymus cancer	0.00486	0.00527	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00456	0.00494	CcSEcCtD
Risedronate—Insomnia—Octreotide—thymus cancer	0.00453	0.00491	CcSEcCtD
Risedronate—Paraesthesia—Octreotide—thymus cancer	0.0045	0.00487	CcSEcCtD
Risedronate—Dyspnoea—Octreotide—thymus cancer	0.00446	0.00484	CcSEcCtD
Risedronate—Dyspepsia—Octreotide—thymus cancer	0.00441	0.00477	CcSEcCtD
Risedronate—Gastrointestinal disorder—Octreotide—thymus cancer	0.00432	0.00468	CcSEcCtD
Risedronate—Fatigue—Octreotide—thymus cancer	0.00432	0.00468	CcSEcCtD
Risedronate—Constipation—Octreotide—thymus cancer	0.00428	0.00464	CcSEcCtD
Risedronate—Pain—Octreotide—thymus cancer	0.00428	0.00464	CcSEcCtD
Risedronate—FDPS—lymph node—thymus cancer	0.00414	0.0539	CbGeAlD
Risedronate—Gastrointestinal pain—Octreotide—thymus cancer	0.00409	0.00444	CcSEcCtD
Risedronate—PTGS2—hematopoietic system—thymus cancer	0.004	0.052	CbGeAlD
Risedronate—Urticaria—Octreotide—thymus cancer	0.00398	0.00431	CcSEcCtD
Risedronate—Body temperature increased—Octreotide—thymus cancer	0.00396	0.00429	CcSEcCtD
Risedronate—Abdominal pain—Octreotide—thymus cancer	0.00396	0.00429	CcSEcCtD
Risedronate—Hypersensitivity—Octreotide—thymus cancer	0.00369	0.004	CcSEcCtD
Risedronate—PTGS2—epithelium—thymus cancer	0.00365	0.0475	CbGeAlD
Risedronate—Asthenia—Octreotide—thymus cancer	0.00359	0.00389	CcSEcCtD
Risedronate—Pruritus—Octreotide—thymus cancer	0.00354	0.00384	CcSEcCtD
Risedronate—Diarrhoea—Octreotide—thymus cancer	0.00343	0.00371	CcSEcCtD
Risedronate—Dizziness—Octreotide—thymus cancer	0.00331	0.00359	CcSEcCtD
Risedronate—Vomiting—Octreotide—thymus cancer	0.00318	0.00345	CcSEcCtD
Risedronate—Rash—Octreotide—thymus cancer	0.00316	0.00342	CcSEcCtD
Risedronate—Dermatitis—Octreotide—thymus cancer	0.00315	0.00342	CcSEcCtD
Risedronate—Headache—Octreotide—thymus cancer	0.00314	0.0034	CcSEcCtD
Risedronate—Nausea—Octreotide—thymus cancer	0.00297	0.00322	CcSEcCtD
Risedronate—PTGS2—pituitary gland—thymus cancer	0.00296	0.0386	CbGeAlD
Risedronate—PTGS2—lymphoid tissue—thymus cancer	0.00281	0.0366	CbGeAlD
Risedronate—PTGS2—bone marrow—thymus cancer	0.00256	0.0333	CbGeAlD
Risedronate—PTGS2—lung—thymus cancer	0.00232	0.0302	CbGeAlD
Risedronate—PTGS2—lymph node—thymus cancer	0.00159	0.0207	CbGeAlD
